close

Somanetics Corporation develops, manufactures, and markets medical devices in the United States, Europe, Canada, the Middle East, South Africa, and Japan. It primarily offers INVOS System, a non-invasive patient monitoring system that measures changes in blood oxygen saturation levels in the brain and in the body in tissues beneath the sensor in patients with or at risk for restricted blood flow. The INVOS System consists of a portable monitoring system used with multiple single-use disposable sensors, known as SomaSensors or OxyAlert sensors. The INVOS System has applications in various market segments, including cardiac and carotid artery surgery, pediatric and neonatal ICU, and diabetic patient surgeries. The INVOS System provides information to the surgeons, anesthesiologists, pediatric and neonatal ICU physicians, and other medical professionals to identify brain and other tissue oxygen imbalances and take necessary action. Somanetics Corporation markets its medical devices directly and through independent sales representative firms, as well as through independent distributors. The company was founded in 1982 and is headquartered in Troy, Michigan.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	24.98
Volume	0
Volume Avg	314977
52 Week High	25.06
52 Week Low	12.90
PE	44.29
PE (group average)	39
EPS Year	0.56
EPS change Q/Q	41.67%
EPS change Q/Q Yr ago	54.55%
EPS change Q/Q next Q est	30.77%
EPS change Y/Y	40.32%
REV change Q/Q	-9.66%
REV change Q/Q Yr ago	16.96%
EPS next Q est	0.13
EPS next Y est	0.75
Divident Annual	0.00
Dividend Yield	0%